Federated Hermes’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
BPC
SCM
RA
AWA
KCM
EIM
Federated Hermes's SOPH Position: Q1 2026 in Review
Federated Hermes increased its SOPHiA GENETICS (SOPH) stake by 1.2% in Q1 2026, buying an estimated $11.3K and bringing the position to 190,010 shares worth $941K. The position accounts for ﹤0.01% of the portfolio, ranked #1132.
Federated Hermes first reported a position in SOPH in Q4 2022 and has held it in 14 quarters since. The position peaked at $1,000K in Q3 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.
- Federated Hermes held 190,010 shares of SOPHiA GENETICS worth $941K as of Q1 2026.
- Federated Hermes bought 2,333 SOPHiA GENETICS shares in Q1 2026, an estimated $11.3K.
- SOPHiA GENETICS made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1132 holding.
- Federated Hermes first reported a position in SOPHiA GENETICS in Q4 2022 and has held it in 14 quarters since.
- Federated Hermes's SOPHiA GENETICS position peaked at $1,000K in Q3 2025.
- 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.